Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int J Med Sci ; 20(10): 1282-1292, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37786447

RESUMO

Rabies continues to be a huge threat to public health. The rabies virus envelope glycoprotein (RABV G) is a major rabies virus antigen and contains neutralizing epitopes, which are primary candidates for subunit vaccines and diagnostic antigens. However, the production and purification of rRABV G while retaining its antigenic and immunogenic remains to be a challenge. Here, we aimed to establish a platform for rRABV G production and purification, and determine the immunogenicity and antigenicity of rRABV G. The cDNA fragment encoding the soluble form of RABV G was synthesized and cloned into a lentiviral expressing vector. Recombinant lentiviral vector LV-CMV-RABV G-eGFP was packaged, titered, and then transduced into HEK 293T cells. The cell culture supernatant was purified using nickel affinity chromatography and subsequently confirmed through Western Blot analysis and indirect enzyme-linked immunosorbent assay (ELISA). The ELISA utilized human sera obtained from individuals who had been vaccinated with the human commercial Purified Vero Cells Rabies Vaccine (PVRV). Notably, we observed a neutralizing antibody response in immunized pigs rather than in mice. This discrepancy could potentially be attributed to factors such as the instability of the rRABV G protein, variations in host responses, and variances in the adjuvant used. Taking all these findings into account, the rRABV G protein generated in this study exhibits promise as a potential vaccine candidate for the prevention of rabies.


Assuntos
Vacina Antirrábica , Vírus da Raiva , Raiva , Chlorocebus aethiops , Humanos , Animais , Camundongos , Suínos , Vírus da Raiva/genética , Raiva/prevenção & controle , Células HEK293 , Células Vero , Anticorpos Antivirais , Glicoproteínas/genética , Vacina Antirrábica/genética , Proteínas do Envelope Viral/genética , Proteínas Recombinantes
2.
Chem Commun (Camb) ; 59(61): 9376-9379, 2023 Jul 27.
Artigo em Inglês | MEDLINE | ID: mdl-37432665

RESUMO

Commercial TS-1 zeolite was functionalized as a stable catalyst for the one-pot transformation of fructose to methyl lactate (MLA) by the reaction solvent (methanol) to generate increased catalytic activity. As a result, TS-1 was recycled for 14 cycles without a regeneration process by calcination and accompanied by a surprising increased catalytic activity. This work is expected to provide a new option for the industrial production of biomass-based MLA by heterogeneous chemocatalysis.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA